THE ROLE OF CISPLATIN IN THE TREATMENT OF RECURRENT HEAD AND NECK CANCER
- 1 January 1980
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cis-platinum and bleomycin infusionCancer, 1979
- Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient scheduleCancer, 1979
- Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck. Preliminary assessment of an intensive drug regimenCancer, 1979
- 24-Hour infusion of cis-platinum in head and neck cancersCancer, 1978
- Chemotherapy for advanced and recurrent squamous cell carcinoma of the head and neck with high and low dose cis-diamminedichloroplatinumThe American Journal of Surgery, 1978
- Weekly administration of cis-diamminedichloroplatinum (II) without hydration or osmotic diuresisEuropean Journal of Cancer (1965), 1978
- The role of chemotherapy in the management of cancer of the head and neck: A reviewCancer, 1975
- Combination Chemotherapy with cis-Diamminedichloroplatinum (II) and Bleomycin in Tumors of the Head and NeckOncology, 1975
- Chemotherapy of cancer of the head and neckCancer, 1973